Pricing Log in Create free account

Lisata Therapeutics, Inc. (LSTA) vs VistaGen Therapeutics, Inc. (VTGN)

Lisata Therapeutics, Inc. and VistaGen Therapeutics, Inc. are both Biotechnology companies. Lisata Therapeutics, Inc. and VistaGen Therapeutics, Inc. are of similar size ($9.6M and $9.5M). VistaGen Therapeutics, Inc. grew revenue faster over the last twelve months: 287.2% against −24.7%. Lisata Therapeutics, Inc. has the higher net margin (0.00% vs −2,703.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Lisata Therapeutics, Inc. leads on 10 and VistaGen Therapeutics, Inc. on 6.

Valuation

Metric LSTA VTGN Biotechnology median
P/E n/m n/m 8.50
P/S 0.62 3.44 9.71
P/B 1.17 0.35 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.21 0.64
EV/Sales 0.14 (5.93) 9.21
Earnings yield (159.22%) (830.00%) (33.15%)
Free cash flow yield (131.69%) (726.47%) (25.50%)

Profitability

Metric LSTA VTGN Biotechnology median
Gross margin 0.49% 100.00% 65.16%
Operating margin 0.00% (2,785.69%) 0.00%
Net margin 0.00% (2,703.72%) 0.00%
Free cash flow margin 0.00% (2,490.88%) 0.00%
Return on equity (101.66%) (166.46%) (56.36%)
Return on assets (80.81%) (129.22%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LSTA VTGN Biotechnology median
Revenue growth (TTM) (24.67%) 287.15% 6.02%
EPS growth (last fiscal year) 20.42% (9.58%) 30.26%
Revenue growth, 5-year CAGR (20.28%) 3.10% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LSTA VTGN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.69 3.07 4.72
Net debt to EBITDA 0.88 0.63 0.96

Dividend

Metric LSTA VTGN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LSTA VTGN Biotechnology median
Market cap 9.64m 9.45m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack